These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1227411)

  • 1. [Oncogenic and antigenic characteristics of ATPC/TC cells].
    Rivosecchi P; Tacconi G
    Ann Sclavo; 1975; 17(2):223-7. PubMed ID: 1227411
    [No Abstract]   [Full Text] [Related]  

  • 2. [Solubilization of antigens from ATPC+ ascitic tumor using hypertonic sodium solution].
    Marconi P; Bistoni F; Pitzurra M
    Boll Soc Ital Biol Sper; 1973 May; 49(10):534-8. PubMed ID: 4132962
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertonic salt solution of superficial membrane proteins from ATPc+ mouse ascites tumour which retain tumour specific antigenic properties.
    Pitzurra M; Marconi P; Bistoni F
    Boll Ist Sieroter Milan; 1973; 52(4):346-8. PubMed ID: 4130350
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3. I. Transplantability, morphology, and some physicochemical characteristics.
    Friberg S
    J Natl Cancer Inst; 1972 May; 48(5):1463-76. PubMed ID: 5030958
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenocarcinoma associated antigen: enhancement of tumor growth with serum from animals bearing adenocarcinoma.
    Hakin AA
    Surg Forum; 1975; 26():175-7. PubMed ID: 1216104
    [No Abstract]   [Full Text] [Related]  

  • 7. A tumour-associated membrane antigen transiently expressed by normal cells during mitosis.
    Bertini M; Forni G; Comoglio PM
    Clin Exp Immunol; 1974 Sep; 18(1):101-8. PubMed ID: 4468189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histocompatibility antigens of 2 transplantable reticulum cell tumors TRH 3 and TRBL 3 (induced in BALB/c/Cb/Se and C57BL/Cb/Se mice with ascites mammary carcinoma ATPC+). I. Transplantability tests].
    Maltzeff N
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1975; 35(1):29-41. PubMed ID: 1243772
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stimulation of pulmonary tumorigenesis by urethane in BALB/c mice pretreated with soluble antigens extracted from a mammary tumor in ascitic form (ATPC+) by use of hypertonic solutions of potassium chloride].
    Ribacchi R
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1974; 34(3):109-14. PubMed ID: 4467024
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival of 125IUDR labeled tumour cells in the blood stream.
    Pitzurra M; Marconi P; Bistoni F; Palumbo R; Corso S
    Boll Ist Sieroter Milan; 1973; 52(4):349-56. PubMed ID: 4777700
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigen specificity and immunogenic capacity of 3m KCl cell extracts from ascites tumour ATPCplus.
    Marconi P; Bistoni F; Pitzurra M
    Boll Ist Sieroter Milan; 1974; 53(2):377-91. PubMed ID: 4214542
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation of fixed antigenic, non-oncogenic and protective neoplastic cells.
    Hakim AA
    Experientia; 1977 Apr; 33(4):518-20. PubMed ID: 862758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic characteristics of metastasizing and nonmetastasizing mammary adenocarcinomata of rat.
    Ghosh SK; Roholt OA; Kim U
    Prog Clin Biol Res; 1983; 133():227-33. PubMed ID: 6622494
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon-mediated modulation of metastasis and MHC antigens.
    Lollini PL; De Giovanni C; Del Re B; Nicoletti G; Prodi G; Scotlandi K; Nanni P
    Adv Exp Med Biol; 1988; 233():129-39. PubMed ID: 3146902
    [No Abstract]   [Full Text] [Related]  

  • 15. Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.
    Cavallo F; Martin-Fontecha A; Bellone M; Heltai S; Gatti E; Tornaghi P; Freschi M; Forni G; Dellabona P; Casorati G
    Eur J Immunol; 1995 May; 25(5):1154-62. PubMed ID: 7539748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice.
    DeLustro F; Haskill JS
    J Natl Cancer Inst; 1980 Jan; 64(1):131-7. PubMed ID: 6928038
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoclonal antibodies directed against breast cancer associated antigens].
    Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
    C R Acad Sci III; 1987; 304(11):313-8. PubMed ID: 2435383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
    Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P
    Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters.
    Paul RD; Ghaffar A; Sigel MM; Charyulu V; Lopez DM
    Anticancer Res; 1981; 1(2):63-9. PubMed ID: 6214206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytotoxic response of rats bearing multicellular spheroids of adenocarcinoma 13762].
    Pelletier G; Osmond L; Laflamme G
    Union Med Can; 1981 Jul; 110(7):669-72. PubMed ID: 7292798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.